714 related articles for article (PubMed ID: 15516861)
1. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
Talbert RL
Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
Bauman JL; Talbert RL
J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
[TBL] [Abstract][Full Text] [Related]
3. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
[TBL] [Abstract][Full Text] [Related]
4. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
5. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
Poole-Wilson PA
Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET.
Cleland JG
Curr Heart Fail Rep; 2004 Jul; 1(2):82-8. PubMed ID: 16036030
[TBL] [Abstract][Full Text] [Related]
8. In heart failure, all beta-blockers are not necessarily equal.
Tang WH; Militello M; Francis GS
Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687
[TBL] [Abstract][Full Text] [Related]
9. Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial.
Packer M
J Card Fail; 2003 Dec; 9(6):429-43. PubMed ID: 14966782
[TBL] [Abstract][Full Text] [Related]
10. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.
Arslan S; Erol MK; Bozkurt E; Acikel M; Gundogdu F; Atesal S; Senocak H
Int J Cardiovasc Imaging; 2007 Oct; 23(5):549-55. PubMed ID: 17171429
[TBL] [Abstract][Full Text] [Related]
11. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
12. How should COMET influence heart failure practice?
Adams KF
Curr Heart Fail Rep; 2004 Jul; 1(2):67-71. PubMed ID: 16036027
[TBL] [Abstract][Full Text] [Related]
13. Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET.
McBride BF; White CM
J Clin Pharmacol; 2005 Jan; 45(1):6-24. PubMed ID: 15601801
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
Hryniewicz K; Androne AS; Hudaihed A; Katz SD
Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS
J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702
[TBL] [Abstract][Full Text] [Related]
16. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers in heart failure. The 'new wave' of clinical trials.
Krum H
Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the effects of carvedilol versus metoprolol on all-cause mortality and hospitalizations in patients with heart failure.
Briasoulis A; Palla M; Afonso L
Am J Cardiol; 2015 Apr; 115(8):1111-5. PubMed ID: 25708861
[TBL] [Abstract][Full Text] [Related]
19. Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?
Doggrell SA
Expert Opin Pharmacother; 2004 Jan; 5(1):205-8. PubMed ID: 14680448
[TBL] [Abstract][Full Text] [Related]
20. Do metoprolol and carvedilol have equivalent effects on diurnal heart rate in patients with chronic heart failure?
Sanderson JE; Leung LY; Chan SK; Yip GW; Fung JW; Yu CM
Eur J Heart Fail; 2005 Aug; 7(5):874-7. PubMed ID: 16043407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
